Navinci and BrainZell announced a collaboration to apply spatial proteomics workflows to brain organoids, using Navinci’s in situ proximity ligation assay (PLA) technology. The effort aims to evaluate how spatial assays can map biological processes and drug response mechanisms in organoid models. The partnership is positioned around functional readouts that preserve spatial context, an increasingly important requirement for translational neuroscience studies where microenvironment and localization drive biology and treatment response. For preclinical platform companies, the deal underscores growing demand for spatial multi-omics tools beyond transcriptomics, particularly for complex tissue models intended to better predict clinical behavior.